A $4.5 Million Vote of Confidence in Hair Tech
Biotech beauty start-up Ruka has secured USD 4.5 million (approx. RM20.7 million) in new hair tech funding, a round co-led by Freedom Trail Capital and Henkel Ventures. The cash injection will fuel the company’s retail growth, scale production of its lab-grown hair extensions and support an expansion into the US market planned for 2026. Additional backing from Big Issue Invest, Backed VC and high-profile angel investors, including Olympic athlete Dina Asher-Smith and supply chain expert Knut Alicke, underscores the breadth of belief in Ruka’s model. Founded in 2020 by Tendai Moyo and Ugo Agbai, Ruka sits at the intersection of textured haircare and material science, already offering human hair extensions, wigs, styling products and tools. The new capital is focused squarely on transforming that portfolio with a next-generation biotech hair fibre platform designed to tackle long-standing concerns around sourcing, safety and sustainability.
Inside Lab-Grown Collagen Protein Hair Fibres
At the heart of Ruka’s pitch is Synths 2, a patent-pending biotech hair fibre made from collagen protein hair technology. Unlike conventional synthetic hair extensions that rely on plastic polymers, this lab-grown hair alternative uses a collagen-based material engineered to look, feel and perform like natural hair. The result is a biodegradable and hypoallergenic fibre, free from plastic and carcinogens, that can be tailored across curls, coils and kinks. Ruka has also filed a patent for shape-memory fibre technology, aiming to ensure the lab-grown strands hold styles and textures the way wearers expect from premium extensions. This approach positions lab-grown hair extensions as sustainable hair alternatives that seek to match performance without the ethical and environmental compromises of traditional options. For consumers increasingly scrutinising ingredients and materials, collagen protein hair fibres offer a compelling mix of innovation, comfort and traceability.
Why Beauty Giants Are Backing Biotech Hair Fibre
Henkel Ventures’ participation in the round signals that major beauty conglomerates now see biotech hair fibre as a strategic frontier. As the venture arm of the group behind established hair brands, Henkel Ventures brings technical, safety and regulatory expertise that Ruka can leverage while it refines its lab-grown hair extensions platform. Investment principal Tobias Botenwerfer points to Ruka’s disciplined execution, clear consumer focus and thoughtful product development as reasons for the partnership. For Henkel, the deal offers early access to an emerging clean hair extensions category that could complement or disrupt traditional product lines. Freedom Trail Capital, meanwhile, highlights how Ruka’s founders built the business through community rather than hype, then pivoted into pioneering hair biotech. Together, these investors are effectively endorsing lab-grown, collagen-based fibres as a credible future pillar of premium haircare rather than a niche experiment.
From Niche Innovation to Global Sustainable Hair Alternatives
The fresh capital positions Ruka to move its lab-grown hair products from early adopters into the mainstream. The company plans to scale manufacturing of Synths 2, deepen research and development, and expand internationally, with the US earmarked as a key growth market. Ruka products are already available in select prestige retail locations, and the brand now aims for broader global distribution across multiple textures and styles. This momentum reflects a wider shift in beauty: consumers and investors are gravitating toward sustainable hair alternatives that reduce reliance on opaque human hair sourcing and plastic-heavy synthetics. By centring textured hair needs and backing that focus with patent-pending biotech, Ruka is shaping a new standard for ethical, performance-driven hair extensions. If the model succeeds, lab-grown hair extensions may soon be less of a curiosity and more of a default choice in the haircare aisle.